New RA drug candidate SOL-116 enters first human safety tests
Disease control
Completed
This early-stage study tested a new drug called SOL-116 in 56 healthy volunteers and people with rheumatoid arthritis. The main goal was to check if the drug is safe and how the body processes it. This is a first step to see if SOL-116 could help control rheumatoid arthritis in t…
Phase: PHASE1 • Sponsor: Lipum AB • Aim: Disease control
Last updated May 17, 2026 04:16 UTC